GEHC GE HealthCare
Data as of close
Nasdaq 100 CompaniesS&P 500 Companies
Healthcare · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
GE HealthCare (GEHC) is a healthcare company in the X-Ray Apparatus & Tubes & Related Irradiation Apparatus industry, with a market capitalization of $36.0 billion. Shares last traded at $79.57, 11.4% below their 52-week high. Over the past year the stock is up 6.0%. GEHC trades at a price-to-earnings ratio of 16.70, in line with the X-Ray Apparatus & Tubes & Related Irradiation Apparatus median of 16.70. Net profit margin is 10.0%, above the peer median of -16.8%. Revenue grew 4.8% year over year. The shares yield 0.2% in dividends.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-09-30. Source: SEC EDGAR/XBRL.
GEHC Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-12-31 | $64M | $0.14 | 3% |
| 2024-12-31 | $55M | $0.12 | 3% |
| 2023-12-31 | $41M | $0.09 | 3% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q3 2026 | $1.36 | 2026-10-28 |
| Q2 2026 | $1.24 | 2026-07-29 |
| Q1 2026 | $0.85 | 2026-04-29 |
| Q4 2025 (derived) | $1.28 | 2026-02-04 |
| FY 2025 | $4.55 | 2026-02-04 |
| Q3 2025 | $0.98 | 2025-10-29 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
X-Ray Apparatus & Tubes & Related Irradiation Apparatus peers
GEHC vs 4 industry peers (X-Ray Apparatus & Tubes & Related Irradiation Apparatus), by market cap. Data as of close
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.